Presentations: Corporate

11 June 2020: ReNeuron Group’s (LON:RENE) Michael Hunt pitches the company to investors at the Proactive One2One Virtual Event. The company’s a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

To view the link please CLICK HERE.

ReNeuron will be presenting at the H.C. Wainwright & Co. global life sciences conference in London on April 9th, 2019.

Details of the conference can be found on our Events page.

The ReNeuron presentation can be accessed by webcast on April 9, 2019 3:30 p.m. (BST)

Click here to register for the webcast…

Olav Hellebo, ReNeuron CEO will be presenting via webcast at the Alliance for Regenerative Medicine : Cell & Gene investor day on March 21, 2019.
ReNeuron’s slot is approximately 9.10am Eastern time (approx. 1.10 pm UK time)
To listen, please follow the link to access further information

Click to access webcast…


14 December 2018: To log on to view a recording of the webcast of the analyst presentation, please click here.

To view the Interim Results Presentation slides please click here.

September 2017: Please click here to see the slides accompanying the AGM Trading Update presentation.